Completed PHASE4 INTERVENTIONAL 2-arm NCT02947178

Hip Arthroscopy Pain Control Randomized Control Trial (RCT)

Liposomal Bupivacaine Versus Bupivacaine With Fascia Iliaca Blockade for Perioperative Pain Management During Hip Arthroscopy: A Double-Blinded Prospective Randomized Control Trial

Sponsor: Walter Reed National Military Medical Center

Conditions Anesthesia Bupivacaine Hip Pain Chronic

Interventions Bupivacaine Fascial iliac regional soft tissue infiltration blockade Liposomal Bupivacaine Pain Score Survey Pill Count

Updated 7 times since 2017 Last updated: Jan 8, 2018 Started: Mar 1, 2016 Primary completion: Mar 1, 2017 Completion: Mar 1, 2017

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02947178, this PHASE4 trial focuses on Anesthesia and Bupivacaine and remains completed. Sponsored by Walter Reed National Military Medical Center, it has been updated 7 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2018 — Jun 2018 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Feb 2017 — Jan 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Feb 2017 [monthly]

Recruiting PHASE4

First recorded

Mar 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Walter Reed National Military Medical Center

Data source: Walter Reed National Military Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bethesda, United States